Durham, N.C.
EMD Pharmaceuticals, a subsidiary of Germany-based Merck KgaA, is building a 148,000-sf marketing, sales, and clinical research facility in Durham. The Indra Group is the developer of the project.
The leader in facility planning and space strategy conferences
